Randomized Study Comparing a Basal-Bolus With a Basal Plus Correction Insulin Regimen for the Hospital Management of Medical and Surgical Patients With Type 2 Diabetes
Open accessThe DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Effective and easily implemented insulin regimens are needed to facilitate hospital glycemic control in general medical and surgical patients with type 2 diabetes (T2D). RESEARCH DESIGN AND METHODS: This multicenter trial randomized 375 patients with T2D treated with diet, oral antidiabetic agents, or low-dose insulin (≤0.4 units/kg/day) to receive a basal-bolus regimen with glargine once daily and glulisine before meals, a basal plus regimen with glargine once daily and supplemental doses of glulisine, and sliding scale regular insulin (SSI). RESULTS: Improvement in mean daily blood glucose (BG) after the first day of therapy was similar between basal-bolus and basal plus groups (P = 0.16), and both regimens resulted in a lower mean daily BG than did SSI (P = 0.04). In addition, treatment with basal-bolus and basal plus regimens resulted in less treatment failure (defined as >2 consecutive BG >240 mg/dL or a mean daily BG >240 mg/dL) than did treatment with SSI (0 vs. 2 vs. 19%, respectively; P < 0.001). A BG <70 mg/dL occurred in 16% of patients in the basal-bolus group, 13% in the basal plus group, and 3% in the SSI group (P = 0.02). There was no difference among the groups in the frequency of severe hypoglycemia (<40 mg/dL; P = 0.76). CONCLUSIONS: The use of a basal plus regimen with glargine once daily plus corrective doses with glulisine insulin before meals resulted in glycemic control similar to a standard basal-bolus regimen. The basal plus approach is an effective alternative to the use of a basal-bolus regimen in general medical and surgical patients with T2D.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Intensive targets result in hypoglycemia, which, in turn, results in higher complications.105,106”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [106]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Intensive insulin therapy in critically ill patients.
Van den Berghe, G., Wouters, P., Weekers, F., Verwaest, C., Bruyninckx, F., Schetz, M., Vlasselaers, D., Ferdinande, P., Lauwers, P., & Bouillon, R. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011300 · Cited by 9,977
Intensive insulin therapy in the medical ICU
Van den Berghe, G., Wilmer, A., Hermans, G., Meersseman, W., Wouters, P. J., Milants, I., Van Wijngaerden, E., Bobbaers, H., & Bouillon, R. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052521 · Cited by 3,639
Standards of Medical Care in Diabetes—2012
(2012) · Diabetes Care · doi:10.2337/dc12-s011 · Cited by 2,240
Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes
Umpierrez, G. E., Isaacs, S. D., Bazargan, N., You, X., Thaler, L. M., & Kitabchi, A. E. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.3.8341 · Cited by 2,195
Self-citationEarly versus late parenteral nutrition in critically ill adults
Casaer, M. P., Mesotten, D., Hermans, G., Wouters, P. J., Schetz, M., Meyfroidt, G., Van Cromphaut, S., Ingels, C., Meersseman, P., Muller, J., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1102662 · Cited by 1,696 · cited 1×
“It is possible that increasing the starting insulin dose and increasing insulin titration will result in better glycemic control; however, it may also increase the risk of hypoglycemic events (28).”
BackgroundMoghissi, E. S., Korytkowski, M. T., DiNardo, M., Einhorn, D., Hellman, R., Hirsch, I. B., Inzucchi, S. E., Ismail-Beigi, F., Kirkman, M. S., & Umpierrez, G. E. (2009) · Diabetes Care · doi:10.2337/dc09-9029 · Cited by 1,444
Self-citationManagement of diabetes and hyperglycemia in hospitals.
Clement, S., Braithwaite, S. S., Magee, M. F., Ahmann, A., Smith, E. P., Schafer, R. G., Hirsch, I. B., & on behalf of the Diabetes in Hospitals Writing Committee (2004) · Diabetes Care · doi:10.2337/diacare.27.2.553 · Cited by 1,266 · cited 1×
“Insulin with oral agents 9 (6) 10 (8) 5 (7)”
Krinsley, J. S. (2003) · Mayo Clinic Proceedings · doi:10.4065/78.12.1471 · Cited by 1,165
Furnary, A. P., Gao, G., Grunkemeier, G. L., Wu, Y., Zerr, K. J., Bookin, S. O., Floten, H. S., & Starr, A. (2003) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1067/mtc.2003.181 · Cited by 1,130 · cited 2×
“The association between hyperglycemia and increased risk of hospital complications is well established in both ICU and non-ICU patients (3,4,6,8,21 – 23).”
BackgroundUmpierrez, G. E., Hellman, R., Korytkowski, M. T., Kosiborod, M., Maynard, G. A., Montori, V. M., Seley, J. J., & Van den Berghe, G. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2098 · Cited by 1,126
Self-citation
Cited by
Handelsman, Y., Bloomgarden, Z. T., Grunberger, G., Umpierrez, G., Zimmerman, R. S., Bailey, T. S., Blonde, L., Bray, G. A., Cohen, A. J., Dagogo-Jack, S., et al. (2015) · Endocrine Practice · doi:10.4158/ep15672.gl · Cited by 629
Self-citationChamberlain, J. J., Rhinehart, A. S., Shaefer, C. F., & Neuman, A. (2016) · Annals of Internal Medicine · doi:10.7326/m15-3016 · Cited by 631
Treatment of Diabetes in Older Adults: An Endocrine Society* Clinical Practice Guideline
LeRoith, D., Biessels, G. J., Braithwaite, S. S., Casanueva, F. F., Draznin, B., Halter, J. B., Hirsch, I. B., McDonnell, M. E., Molitch, M. E., Murad, M. H., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00198 · Cited by 568
Diabetic emergencies - ketoacidosis, hyperglycaemic hyperosmolar state and hypoglycaemia
Umpierrez, G., & Korytkowski, M. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.15 · Cited by 563
Self-citationHandelsman, Y., Bloomgarden, Z. T., Grunberger, G., Umpierrez, G., Zimmerman, R. S., Bailey, T. S., Blonde, L., Bray, G. A., Cohen, A. J., Dagogo-Jack, S., et al. (2015) · Endocrine Practice · doi:10.4158/ep15672.glsuppl · Cited by 559
Self-citationBlonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
Self-citation16. Diabetes Care in the Hospital: Standards of Medical Care in Diabetes—2022
American Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s016 · Cited by 440
“In noncardiac general surgery patients, basal insulin plus premeal short- or rapid-acting insulin (basal-bolus) coverage has been associated with improved glycemic control and lower rates of perioperative complications compared with the reactive, sliding scale regimens (short- or rapid-acting insulin coverage only wit…”
BackgroundPerioperative Hyperglycemia Management: An Update
Duggan, E. W., Carlson, K., & Umpierrez, G. E. (2017) · Anesthesiology · doi:10.1097/aln.0000000000001515 · Cited by 402
Self-citationManagement of diabetes and hyperglycaemia in the hospital
Pasquel, F. J., Lansang, M. C., Dhatariya, K., & Umpierrez, G. E. (2021) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(20)30381-8 · Cited by 329
Self-citationKorytkowski, M. T., Muniyappa, R., Antinori-Lent, K., Donihi, A. C., Drincic, A. T., Hirsch, I. B., Luger, A., McDonnell, M. E., Murad, M. H., Nielsen, C., et al. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac278 · Cited by 315
Self-citation15. Diabetes Care in the Hospital: Standards of Medical Care in Diabetes—2020
American Diabetes Association (2020) · Diabetes Care · doi:10.2337/dc20-s015 · Cited by 265
Diabetes Technology Update: Use of Insulin Pumps and Continuous Glucose Monitoring in the Hospital
Umpierrez, G. E., & Klonoff, D. C. (2018) · Diabetes Care · doi:10.2337/dci18-0002 · Cited by 251
Self-citation16. Diabetes Care in the Hospital: Standards of Care in Diabetes—2023
ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Hilliard, M. E., Isaacs, D., Johnson, E. L., et al. (2023) · Diabetes Care · doi:10.2337/dc23-s016 · Cited by 221
15. Diabetes Care in the Hospital: Standards of Medical Care in Diabetes—2019
American Diabetes Association (2019) · Diabetes Care · doi:10.2337/dc19-s015 · Cited by 216
15. Diabetes Care in the Hospital: Standards of Medical Care in Diabetes—2021
American Diabetes Association (2021) · Diabetes Care · doi:10.2337/dc21-s015 · Cited by 197
14. Diabetes Care in the Hospital: Standards of Medical Care in Diabetes—2018
American Diabetes Association (2018) · Diabetes Care · doi:10.2337/dc18-s014 · Cited by 178
Pasquel, F. J., Gianchandani, R., Rubin, D. J., Dungan, K. M., Anzola, I., Gomez, P. C., Peng, L., Hodish, I., Bodnar, T., Wesorick, D., et al. (2017) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(16)30402-8 · Cited by 168
Self-citationUmpierrez, G. E., Gianchandani, R., Smiley, D., Jacobs, S., Wesorick, D. H., Newton, C., Farrokhi, F., Peng, L., Reyes, D., Lathkar-Pradhan, S., et al. (2013) · Diabetes Care · doi:10.2337/dc13-0277 · Cited by 166
Self-citationManagement of Inpatient Hyperglycemia and Diabetes in Older Adults
Umpierrez, G. E., & Pasquel, F. J. (2017) · Diabetes Care · doi:10.2337/dc16-0989 · Cited by 159
Self-citationOptimized glycemic control of type 2 diabetes with reinforcement learning: a proof-of-concept trial
Wang, G., Liu, X., Ying, Z., Yang, G., Chen, Z., Liu, Z., Zhang, M., Yan, H., Lu, Y., Gao, Y., et al. (2023) · Nature Medicine · doi:10.1038/s41591-023-02552-9 · Cited by 156
Insulin Therapy for Type 2 Diabetes Mellitus
Wallia, A., & Molitch, M. E. (2014) · JAMA · doi:10.1001/jama.2014.5951 · Cited by 153
Stress-Induced Hyperglycemia: Consequences and Management
Vedantam, D., Poman, D. S., Motwani, L., Asif, N., Patel, A., & Anne, K. K. (2022) · Cureus · doi:10.7759/cureus.26714 · Cited by 254
“However, critically ill patients not in an ICU and with blood glucose levels above 10 mmol/ L must still be treated with intravenous insulin therapy [75,76].”
BackgroundUmpierrez, G. E., Reyes, D., Smiley, D., Hermayer, K., Khan, A., Olson, D. E., Pasquel, F., Jacobs, S., Newton, C., Peng, L., et al. (2014) · Diabetes Care · doi:10.2337/dc14-0479 · Cited by 130
Self-citationBellido, V., Suarez, L., Rodriguez, M. G., Sanchez, C., Dieguez, M., Riestra, M., Casal, F., Delgado, E., Menendez, E., & Umpierrez, G. E. (2015) · Diabetes Care · doi:10.2337/dc15-0160 · Cited by 118
Self-citationConlin, P. R., Colburn, J., Aron, D., Pries, R. M., Tschanz, M. P., & Pogach, L. (2017) · Annals of Internal Medicine · doi:10.7326/m17-1362 · Cited by 97
Glycaemic control in the perioperative period
Sebranek, J. J., Lugli, A. K., & Coursin, D. B. (2013) · British Journal of Anaesthesia · doi:10.1093/bja/aet381 · Cited by 101
Perioperative management of hyperglycemia and diabetes in cardiac surgery patients
Galindo, R. J., Fayfman, M., & Umpierrez, G. E. (2018) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2017.10.005 · Cited by 95
Self-citation14. Diabetes Care in the Hospital
American Diabetes Association (2016) · Diabetes Care · doi:10.2337/dc17-s017 · Cited by 110
Kyi, M., Colman, P. G., Wraight, P. R., Reid, J., Gorelik, A., Galligan, A., Kumar, S., Rowan, L. M., Marley, K. A., Nankervis, A. J., et al. (2019) · Diabetes Care · doi:10.2337/dc18-2342 · Cited by 86
13. Diabetes Care in the Hospital
American Diabetes Association (2015) · Diabetes Care · doi:10.2337/dc16-s016 · Cited by 103
Fayfman, M., Galindo, R. J., Rubin, D. J., Mize, D. L., Anzola, I., Urrutia, M. A., Ramos, C., Pasquel, F. J., Haw, J. S., Vellanki, P., et al. (2019) · Diabetes Care · doi:10.2337/dc18-1760 · Cited by 85
Self-citationVellanki, P., Rasouli, N., Baldwin, D., Alexanian, S., Anzola, I., Urrutia, M., Cardona, S., Peng, L., Pasquel, F. J., Umpierrez, G. E., et al. (2019) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13587 · Cited by 80
“The percentage of participants with hypoglycaemia in the basal-bolus group in the current study was lower than that in our previous studies in which the rate of hypoglycaemia ranged from 16% to 23%.(15,22,23) In our current study, despite receiving similar amounts of supplemental insulin, only two participants in the…”
BackgroundResultSelf-citationThe clinical impact of inpatient hypoglycemia
Brutsaert, E. F., Carey, M., & Zonszein, J. (2014) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2014.03.002 · Cited by 78
Seisa, M. O., Saadi, S., Nayfeh, T., Muthusamy, K., Shah, S. H., Firwana, M., Hasan, B., Jawaid, T., Abd-Rabu, R., Korytkowski, M. T., et al. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac277 · Cited by 65
Perioperative Evaluation and Management of Endocrine Disorders
Himes, C. P., Ganesh, R., Wight, E. C., Simha, V., & Liebow, M. (2020) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2020.05.004 · Cited by 65
Christensen, M. B., Gotfredsen, A., & Nørgaard, K. (2017) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2885 · Cited by 57
Pasquel, F. J., Fayfman, M., & Umpierrez, G. E. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1184-8 · Cited by 60
Self-citationBueno, E., Benitez, A., Rufinelli, J., Figueredo, R., Alsina, S., Ojeda, A., Samudio, S., Cáceres, M., Argüello, R., Romero, F., et al. (2015) · Endocrine Practice · doi:10.4158/ep15675.or · Cited by 56
Self-citationPasquel, F. J., Gomez-Huelgas, R., Anzola, I., Oyedokun, F., Haw, J. S., Vellanki, P., Peng, L., & Umpierrez, G. E. (2015) · Diabetes Care · doi:10.2337/dc15-1835 · Cited by 55
Self-citationIn-hospital management of diabetes
Malcolm, J., Halperin, I., Miller, D. B., Moore, S., Nerenberg, K. A., Woo, V., & Yu, C. H. (2018) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2017.10.014 · Cited by 55
Lee, Y.-Y., Lin, Y.-M., Leu, W.-J., Wu, M.-Y., Tseng, J.-H., Hsu, M.-T., Tsai, C.-S., Hsieh, A.-T., & Tam, K.-W. (2015) · Metabolism · doi:10.1016/j.metabol.2015.05.011 · Cited by 51
Neubauer, K. M., Mader, J. K., Höll, B., Aberer, F., Donsa, K., Augustin, T., Schaupp, L., Spat, S., Beck, P., Fruhwald, F. M., et al. (2015) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2015.0027 · Cited by 51
Donsa, K., Spat, S., Beck, P., Pieber, T. R., & Holzinger, A. (2015) · Lecture notes in computer science · doi:10.1007/978-3-319-16226-3_10 · Cited by 60
Schaupp, L., Donsa, K., Neubauer, K. M., Mader, J. K., Aberer, F., Höll, B., Spat, S., Augustin, T., Beck, P., Pieber, T. R., et al. (2015) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2014.0343 · Cited by 47
Pharmacotherapy for Hyperglycemia in Noncritically Ill Hospitalized Patients
Mendez, C. E., & Umpierrez, G. E. (2014) · Diabetes Spectrum · doi:10.2337/diaspect.27.3.180 · Cited by 46
Self-citationSliding scale insulin for non-critically ill hospitalised adults with diabetes mellitus
Colunga-Lozano, L. E., Gonzalez Torres, F. J., Delgado-Figueroa, N., Gonzalez-Padilla, D. A., Hernandez, A. V., Roman, Y., & Cuello-García, C. A. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011296.pub2 · Cited by 45
“…Outcome High risk of bias (category A)a High risk of bias (category D)b High risk of bias (category E)c High risk of bias (category G)d Said 2013 N/D Umpierrez 2013 N/D Schroeder 2012 Hypoglycaemic events, other adverse events Yes Yes No No Umpierrez 2011 N/D Korytkowski 2009 N/D Umpierrez 2007a…”
BackgroundMethodInfluentialPasquel, F. J., Lansang, M. C., Khowaja, A., Urrutia, M. A., Cardona, S., Albury, B., Galindo, R. J., Fayfman, M., Davis, G., Migdal, A., et al. (2020) · Diabetes Care · doi:10.2337/dc19-1940 · Cited by 45
Self-citationUpdate on the management of diabetes in long-term care facilities
Idrees, T., Castro-Revoredo, I. A., Migdal, A. L., Moreno, E. M., & Umpierrez, G. E. (2022) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2021-002705 · Cited by 44
Self-citationInsulin Therapy in Hospitalized Patients
Pérez, A., Ramos, A., & Carreras, G. (2020) · American Journal of Therapeutics · doi:10.1097/mjt.0000000000001078 · Cited by 45
Inpatient hyperglycemia management: A practical review for primary medical and surgical teams
Lansang, M. C., & Umpierrez, G. E. (2016) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.83.s1.06 · Cited by 50
Self-citationUmpierrez, G. E., Cardona, S., Chachkhiani, D., Fayfman, M., Saiyed, S., Wang, H., Vellanki, P., Haw, J. S., Olson, D. E., Pasquel, F. J., et al. (2018) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2017.11.002 · Cited by 43
Self-citationFushimi, N., Shibuya, T., Yoshida, Y., Ito, S., Hachiya, H., & Mori, A. (2020) · Journal of Diabetes Investigation · doi:10.1111/jdi.13093 · Cited by 41
Practical Recommendations for Transitioning Patients with Type 2 Diabetes from Hospital to Home
Donihi, A. C. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0876-1 · Cited by 47
Perioperative glycemic management in adults presenting for elective cardiac and non-cardiac surgery
Sreedharan, R., Khanna, S. K., & Shaw, A. (2023) · Perioperative Medicine · doi:10.1186/s13741-023-00302-6 · Cited by 70
Duggan, E. W., Klopman, M. A., Berry, A. J., & Umpierrez, G. E. (2016) · Current Diabetes Reports · doi:10.1007/s11892-016-0720-z · Cited by 39
Self-citationDiabetic foot infections: recent literature and cornerstones of management
Uçkay, İ., Gariani, K., Dubois-Ferrière, V., Suvà, D., & Lipsky, B. A. (2016) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000243 · Cited by 38
Vellanki, P., Bean, R., Oyedokun, F. A., Pasquel, F. J., Smiley, D., Farrokhi, F., Newton, C., Peng, L., & Umpierrez, G. E. (2015) · Diabetes Care · doi:10.2337/dc14-1796 · Cited by 36
Self-citationEna, J., Gómez‐Huelgas, R., Romero-Sánchez, M., Gaviria, A. Z., Calzada-Valle, A., Varela-Aguilar, J. M., Bernal, M., Garcia-Contreras, R., Berdún-Chéliz, M. A., Gracia-Tello, B., et al. (2015) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2015.04.020 · Cited by 40
Donsa, K., Beck, P., Höll, B., Mader, J. K., Schaupp, L. A., Plank, J., Neubauer, K. M., Baumgärtner, C., & Pieber, T. R. (2016) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2016.03.007 · Cited by 40
Enhanced Recovery After Surgery (ERAS®) in Individuals with Diabetes: A Systematic Review
Albalawi, Z., Laffin, M., Gramlich, L. M., Senior, P. A., & McAlister, F. A. (2017) · World Journal of Surgery · doi:10.1007/s00268-017-3982-y · Cited by 32
Galindo, R. J., Dhatariya, K., Peralta, F. G., & Umpierrez, G. E. (2022) · Current Diabetes Reports · doi:10.1007/s11892-022-01464-1 · Cited by 36
Self-citationSpat, S., Donsa, K., Beck, P., Höll, B., Mader, J. K., Schaupp, L. A., Augustin, T., Chiarugi, F., Lichtenegger, K. M., Plank, J., et al. (2016) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816676501 · Cited by 29
Migdal, A. L., Fortin‐Leung, C., Pasquel, F., Wang, H., Peng, L., & Umpierrez, G. E. (2021) · Journal of Hospital Medicine · doi:10.12788/jhm.3654 · Cited by 28
Self-citationGalindo, R. J., Pasquel, F. J., Vellanki, P., Alicic, R., Lam, D. W., Fayfman, M., Migdal, A. L., Davis, G. M., Cardona, S., Urrutia, M. A., et al. (2022) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14544 · Cited by 26
“Patients with poor oral intake, or who were kept nil per os or nothing by mouth, received the basal dose, but the prandial dose was held.(8) All patients also received additional aspart doses to correct for hyperglycaemia up to four times a day as per a standard hospital protocol.”
Self-citationPérez, A., Reales, P., Barahona, M. J., Romero, M. G., Miñambres, I., & the HOSMIDIA Study Group (2014) · International Journal of Clinical Practice · doi:10.1111/ijcp.12498 · Cited by 30
Hakeam, H. A., Mulia, H. A., Azzam, A. Z., & Amin, T. M. (2016) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607116644710 · Cited by 32
Inpatient Diabetes Management in the Twenty-First Century
Khazai, N. B., & Hamdy, O. (2016) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2016.06.013 · Cited by 33
Pasquel, F. J., Urrutia, M. A., Cardona, S., Zamudio-Coronado, K. W., Albury, B. S., Perez‐Guzman, M. C., Galindo, R. J., Chaudhuri, A., Iacobellis, G., Palacios, J. D., et al. (2021) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14347 · Cited by 27
Self-citationAberer, F., Lichtenegger, K. M., Smajic, E., Donsa, K., Malle, O., Samonigg, J., Höll, B., Beck, P., Pieber, T. R., Plank, J., et al. (2018) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13559 · Cited by 25
“8 mmol/L (primary outcome) was greater than that of a comparable best-practice study with the criterion threshold of 42%.(16) To ensure that calculation of the primary endpoint was based on BG data of at least 27 patients, the planned number of patients was increased to 30.”
MethodResultInfluentialInpatient Hyperglycemia Management and COVID-19
Bellido, V., & Pérez, A. (2020) · Diabetes Therapy · doi:10.1007/s13300-020-00966-z · Cited by 27
“A basal plus regimen compared with a standard basal-bolus regimen in medical and surgical patients with type 2 diabetes treated with diet, oral antidiabetic agents, or low-dose insulin resulted in a similar improvement in glycemic control without differences in hypoglycemia [54].”
MethodGerards, M. C., de Maar, J. S., Steenbruggen, T. G., Hoekstra, J. B. L., Vriesendorp, T. M., & Gerdes, V. E. A. (2016) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12694 · Cited by 22
Prevention and Management of Insulin-Associated Hypoglycemia in Hospitalized Patients
Mathioudakis, N. N., Everett, E. M., & Golden, S. H. (2016) · Endocrine Practice · doi:10.4158/ep151119.or · Cited by 23
Outcomes of “Real-World” Insulin Strategies in the Management of Hospital Hyperglycemia
Sadhu, A., Patham, B., Vadhariya, A., Chikermane, S. G., & Johnson, M. L. (2021) · Journal of the Endocrine Society · doi:10.1210/jendso/bvab101 · Cited by 21
“Surprisingly, this follow-up study demonstrated that a basal-plus insulin regimen resulted in similar glycemic control to BB regimen but again with more hypoglycemia than SS [25].”
ResultDiabetes management before, during, and after bariatric and metabolic surgery
Kheniser, K. G., & Kashyap, S. R. (2018) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2018.06.006 · Cited by 20
Advances in the management of hyperglycaemia and diabetes mellitus during hospitalization
Idrees, T., Castro-Revoredo, I., Dhatariya, K., Hernandez, L., & Umpierrez, G. E. (2025) · Nature Reviews Endocrinology · doi:10.1038/s41574-025-01157-1 · Cited by 25
Self-citationEvaluation of the timing and coordination of prandial insulin administration in the hospital
Alwan, D., Chipps, E., Yen, P.-Y., & Dungan, K. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.06.021 · Cited by 18
A Systematic Approach for the Prevention and Reduction of Hypoglycemia in Hospitalized Patients
Cruz, P., Blackburn, M. C., & Tobin, G. S. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0934-8 · Cited by 20
Flory, J. H., Aleman, J. O., Furst, J., & Seley, J. J. (2014) · Journal of Diabetes Science and Technology · doi:10.1177/1932296813520367 · Cited by 17
“Guidelines recommend use of insulin to prevent hyperglycemia in hospitalized patients,(1,2) and randomized trials have shown that regimens that include basal insulin are more effective than rapid-acting insulin alone.(3-5) These trials also show that basal insulin increases the rate of hypoglycemia, a fact that likely…”
BackgroundPerez, A., Carrasco-Sánchez, F. J., González, C., Seguí-Ripoll, J. M., Trescolí, C., Ena, J., Borrell, M., & Gomez Huelgas, R. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-001518 · Cited by 16
Positionspapier: Operation und Diabetes mellitus (Update 2023)
Kietaibl, A.-T., Huber, J., Clodi, M., Abrahamian, H., Ludvik, B. H., & Fasching, P. (2023) · Wiener klinische Wochenschrift · doi:10.1007/s00508-022-02121-z · Cited by 19
Toyoshima, M. T. K., de Souza, A. B. C., Admoni, S. N., Cukier, P., Lottenberg, S. A., Latronico, A. C., & Nery, M. (2015) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-015-0111-7 · Cited by 21
Self-citationGosmanov, A. R. (2016) · Journal of Clinical & Translational Endocrinology · doi:10.1016/j.jcte.2016.05.002 · Cited by 19
Inpatient Management of T2DM and Hyperglycemia in Older Adults
DeCarlo, K., & Wallia, A. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1209-3 · Cited by 17
Lichtenegger, K. M., Aberer, F., Tuca, A., Donsa, K., Höll, B., Schaupp, L. A., Plank, J., Beck, P., Fruhwald, F. M., Kamolz, L., et al. (2020) · Journal of Diabetes Science and Technology · doi:10.1177/1932296820955243 · Cited by 15
Chen, Y., Chen, Z., Zhao, L., Li, S., Ying, Z., Yu, P., Yan, H., Chen, H., Yang, C., Zhang, J., et al. (2023) · Current Medicine · doi:10.1007/s44194-023-00020-7 · Cited by 21
“And the percentage of pre-prandial blood glucose in target range (5.6–7.8) was from 31.8% at the first 24 h to 56% in the last 24 h, which was comparable to previous best-practice study (Umpierrez et al., 2013; Umpierrez et al., 2007).”
ResultInfluentialBossi, A. C., Veronesi, G., Poerio, C. S., Braus, A., Madaschi, S., Destro, M., Ferraro, B., Gilberti, L., Sganzerla, P., & Davis, E. M. (2015) · Current Diabetes Reviews · doi:10.2174/1573399811666150806150210 · Cited by 15
RSSDI consensus recommendations on insulin therapy in the management of diabetes
(extended), E. P., Chawla, R., Makkar, B. M., Aggarwal, S., Bajaj, S., Das, A. K., Ghosh, S. K., Gupta, A., Gupta, S., Jaggi, S., et al. (2019) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-019-00783-6 · Cited by 17
Cardona, S., TSEGKA, K. G., Pasquel, F. J., Jacobs, S., Halkos, M. E., Keeling, W. B., Davis, G. M., Fayfman, M., Albury, B. S., Urrutia, M. A., et al. (2020) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14241 · Cited by 16
“2 mmol/L (201-400 mg/dL).(17) Patients older than 70 years or with impaired renal function (eGFR < 50 mL/min/1.”
BackgroundMethodSelf-citationKuchay, M. S., Khatana, P., Mishra, M., Surendran, P., Kaur, P., Wasir, J. S., Gill, H. K., Singh, A., Jain, R., Kohli, C., et al. (2023) · Acta Diabetologica · doi:10.1007/s00592-023-02138-4 · Cited by 16
RSSDI clinical practice recommendations for management of In-hospital hyperglycaemia—2016
Panikar, V., Sosale, A., Agarwal, S., Unnikrishnan, A., Kalra, S., Bhattacharya, A. D., Chawla, M. S., Anjana, R. M., Bhatt, A., Jaggi, S., et al. (2016) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-016-0528-z · Cited by 15
Aberer, F., Mader, J. K., Holzgruber, J., Trummer, C., Theiler‐Schwetz, V., Pandis, M., Pferschy, P. N., Greinix, H. T., Tripolt, N. J., Pieber, T. R., et al. (2018) · Journal of Diabetes Investigation · doi:10.1111/jdi.12919 · Cited by 13
Panayi, A. C., Knoedler, S. A., Alfertshofer, M. G., Matar, D. Y., Friedrich, S., Rühl, J., Haug, V., Gazyakan, E., Bigdeli, A. K., Kneser, U., et al. (2025) · Annals of Surgery · doi:10.1097/sla.0000000000006664 · Cited by 20
Smiley, D. D., Umpierrez, G. E., Hermayer, K. L., Newton, C. A., Jacobs, S., Olson, D. E., Khan, A., Rizzo, M., Peng, L., Reyes, D., et al. (2013) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2013.05.007 · Cited by 15
“A uthor M anuscript A uthor M anuscript A uthor M anuscript A uthor M anuscript In the Basal Plus trial (Umpierrez et al., 2013) we randomized general medicine and surgery patients with T2D treated with diet, oral antidiabetic agents or low-dose insulin therapy (≤0.4 U/kg/day) to receive treatment…”
InfluentialSelf-citationCardona, S., TSEGKA, K. G., Pasquel, F. J., Fayfman, M., Peng, L., Jacobs, S., Vellanki, P., Halkos, M. E., Guyton, R. A., Thourani, V. H., et al. (2019) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2019-000703 · Cited by 12
Self-citationChallenges and Strategies for Inpatient Diabetes Management in Older Adults
Gosmanov, A. R., Mendez, C. E., & Umpierrez, G. E. (2020) · Diabetes Spectrum · doi:10.2337/ds20-0008 · Cited by 13
Self-citationDhatariya, K., & Umpierrez, G. E. (2022) · Diabetic Medicine · doi:10.1111/dme.14980 · Cited by 11
Self-citationSimioni, N., Filippi, A., Scardapane, M., Nicolucci, A., Rossi, M. C., & Frison, V. (2017) · Diabetes Therapy · doi:10.1007/s13300-017-0271-6 · Cited by 13
Vellanki, P., Cardona, S., Galindo, R. J., Urrutia, M. A., Pasquel, F. J., Davis, G. M., Fayfman, M., Migdal, A., Peng, L., & Umpierrez, G. E. (2022) · Diabetes Care · doi:10.2337/dc21-1606 · Cited by 10
Self-citationPremixed Insulin Analogue Compared with Basal-Plus Regimen for Inpatient Glycemic Control
Gracia‐Ramos, A. E., Cruz-Domínguez, M. P., Madrigal‐Santillán, E., Morales‐González, J. A., Madrigal‐Bujaidar, E., & Aguilar-Faisal, L. (2016) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2016.0176 · Cited by 13
“30 A recent study by Bellido et al. compared the efficacy and safety of a premixed human insulin regimen (30% regular insulin and 70% NPH insulin) twice daily with basal-bolus regimen (glargine once daily and glulisine before meals) in medical and surgical patients with T2D and reported a mean daily…”
Donihi, A. C., Moorman, J. M., Abla, A., Hanania, R., Carneal, D., & MacMaster, H. W. (2018) · JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY · doi:10.1002/jac5.1041 · Cited by 12
“39 We recommend basal plus correction insulin as the initial regimen in patients who only use basal insulin or are insulin-naïve prior to hospitalization.”
Method
Metadata
- Authors
- Umpierrez, G. E., Smiley, D., Hermayer, K., Khan, A., Olson, D. E., Newton, C., Jacobs, S., Rizzo, M., Peng, L., Reyes, D., Pinzon, I., Fereira, M. E., Hunt, V., Gore, A., Toyoshima, M. T., & Fonseca, V. A.
- Affiliations
- Emory University (US)
- Medical University of South Carolina (US)
- Tulane Medical Center (US)
- Corresponding author
- Umpierrez, Guillermo E.
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2013-07-11
- Volume
- 36
- Issue
- 8
- Pages
- 2169-2174
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC3714500
- OpenAlex
- W2113123801
- Cited by
- 222
- References
- 29
- Citations by year
- 2026: 9 · 2025: 15 · 2024: 11 · 2023: 13 · 2022: 15 · 2021: 19 · 2020: 18 · 2019: 17 · 2018: 20 · 2017: 17 · 2016: 27 · 2015: 23 · 2014: 14 · 2013: 4
- FWCI
- 17.83
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (UL1TR000454)
- National Institute of General Medical Sciences (U54GM104940)
- National Center for Research Resources (UL1RR025008)
- National Center for Advancing Translational Sciences
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- type 2 diabetes, multiple daily insulin injections, glargine, glulisine, sliding scale insulin, hypoglycemia, hyperglycemia, surgical patients, medical patients
- MeSH terms
- Insulin Glargine, Adult, Aged, Blood Glucose, Diabetes Mellitus, Type 2, Female, Hospitalization, Humans, Hypoglycemic Agents, Insulin, Male, Middle Aged, Surgical Procedures, Operative, Treatment Outcome, Insulin, Long-Acting, Meals
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
